Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.65 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3080983 | 0.83 | SMN1; SMN2 (0.69) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL22518481 | 0.82 | RAB9A (0.57) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL11321854 | 0.81 | RAB9A (0.53) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL10491015 | 0.80 | RAB9A (0.56) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL8384059 | 0.80 | SMN1; SMN2 (0.65) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL11856575 | 0.80 | RAB9A (0.65) | RAB9ASMN1; SMN2HSD17B10TSHRKMT2A | |
| SCHEMBL6682364 | 0.80 | SMN1; SMN2 (0.65) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL28834690 | 0.80 | SMN1; SMN2 (0.65) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL9082472 | 0.80 | SMN1; SMN2 (0.65) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR | |
| SCHEMBL28872509 | 0.80 | SMN1; SMN2 (0.65) | RAB9ASMN1; SMN2NAPRTHSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138356-B2 | Chemical inhibitors of inhibitors of differentiation | Angiogeney, Inc. (US) | 2012-03-20 | — | — | US | disclosed |
| US-20090226422-A1 | Chemical Inhibitors of Inhibitors of Differentiation | ANGIOGENEX | 2009-09-10 | — | — | US | disclosed |
| WO-1996034866-A1 | IMIDAZO 1,2-A PYRIDINE AND IMIDAZO 1,2-A PYRIDEZINE DERIVATIVES AND THEIR USE AS BONE RESORPTION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-07 | — | — | WO | disclosed |
| CN-1077707-A | The method for preparing p-aminophenol | RHONE POULENC CHIMIE (FR) | 1993-10-27 | — | — | CN | disclosed |
| US-4296128-A | ANTITHROMBOSIS AGENTS | CIBA-GEIGY CORPORATION (US) | 1981-10-20 | — | — | US | disclosed |
| EP-0019587-A1 | Carboxylic acid hydrazides, process for their preparation, their use and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1980-11-26 | — | — | EP | disclosed |
| US-4179439-A | Rifamycins and method for their preparation | INTREPRINDEREA DE ANTIBIOTICE IASI (RO) | 1979-12-18 | — | — | US | disclosed |
| US-4150139-A | MUSCLE RELAXANTS, ANALGESICS, ANTIINFLAMMATORY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1979-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090226422-A1 | Chemical Inhibitors of Inhibitors of Differentiation | BRAF, MAPK1, RAF1 | RAB9A 1023/4885SMN1; SMN2 3141/4885NAPRT 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.